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We present a detailed response to the critique of “State of the Science of Endocrine Disrupting Chemicals
2012” (UNEP/WHO, 2013) by ﬁnancial stakeholders, authored by Lamb et al. (2014). Lamb et al.'s claim
that UNEP/WHO (2013) does not provide a balanced perspective on endocrine disruption is based on
incomplete and misleading quoting of the report through omission of qualifying statements and inaccurate description of study objectives, results and conclusions. Lamb et al. deﬁne extremely narrow
standards for synthesizing evidence which are then used to dismiss the UNEP/WHO 2013 report as
ﬂawed. We show that Lamb et al. misuse conceptual frameworks for assessing causality, especially the
BradfordeHill criteria, by ignoring the fundamental problems that exist with inferring causality from
empirical observations. We conclude that Lamb et al.'s attempt of deconstructing the UNEP/WHO (2013)
report is not particularly erudite and that their critique is not intended to be convincing to the scientiﬁc
community, but to confuse the scientiﬁc data. Consequently, it promotes misinterpretation of the UNEP/
WHO (2013) report by non-specialists, bureaucrats, politicians and other decision makers not intimately
familiar with the topic of endocrine disruption and therefore susceptible to false generalizations of bias
and subjectivity.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
In 2013, the United Nations Environmental Programme (UNEP)
and the World Health Organization (WHO) published a report
“State of the Science of Endocrine Disrupting Chemicals e 2012”
(UNEP/WHO, 2013) and a companion report “State of the Science of
Endocrine Disrupting Chemicals 2012 e Summary for DecisionMakers” (UNEP/WHO, 2013b). The reports were prepared in the
context of United Nations (UN) activities in recognition of human
health and biodiversity, to take stock of new ﬁndings, to identify
key concerns and future needs. The two UNEP/WHO reports were
speciﬁcally developed in connection with the Strategic Approach to
International Chemicals Management (SAICM), a UN policy
framework established by the UN International Conference on
Chemicals Management (ICCM). The objective of SAICM is to achieve the sound management of chemicals throughout their life
cycle so that, by 2020, chemicals are used and produced in ways
that minimize signiﬁcant adverse effects on human health and the
environment. On the basis of the evidence assembled by UNEP/
WHO (2013), ICCM decided in September 2012 to include endocrine disrupting chemicals (EDCs) as an emerging issue under
SAICM.
As scientists with research expertise in the ﬁeld of endocrine
disruption, we were charged by UNEP and WHO ofﬁcials in a faceto-face meeting to prepare the UNEP/WHO (2013) report which
was intended as an update of the earlier WHO-IPCS report on the
subject (IPCS 2002) and to which some of us had also contributed.
The new report was reviewed by 23 endocrine disruption experts
from 12 countries, with additional extensive critical reviews conducted by UNEP and WHO staff.
We served in a personal capacity, and not as representatives of
any organization, government or industry, to prepare the two reports (UNEP/WHO, 2013a; b). We signed Declaration of Interest
statements, and no conﬂicts of interest were identiﬁed. The
development and publication of the report was supported by funds
provided to UNEP from the Norwegian government, the Swedish
Environment Ministry, the Swedish Research Council (FORMAS)
and the Swedish Environmental Protection Agency, with additional
support to WHO from the United States National Institute of
Environmental Health Sciences (NIEHS).
The UNEP/WHO report has been criticized by a group of authors
(Lamb et al., 2014) who received funding support from several industrial organizations with ﬁnancial stakes in chemical production,
including American Chemistry Council (ACC), CropLife America
(CLA), CropLife Canada (CLS), CropLife International (CLI), European
Chemical Industry Council (Ceﬁc), and European Crop Protection
Association (ECPA).
In their critique, Lamb et al. maintain that UNEP/WHO (2013)
does not provide a balanced perspective on endocrine disruption,
because scientiﬁc evidence was cited in a biased way, with a preference toward studies reporting exposure-disease associations, and
without evaluations of the quality of underlying studies. They
conclude that the report is neither a state-of-the-science review,
nor an update of the earlier WHO/IPCS (2002) report. Lamb et al.
(2014) support these conclusions by expressing several speciﬁc
concerns relating directly to the content and narrative of UNEP/
WHO (2013): 1) failure to apply a systematic framework for identifying, reviewing and evaluating data, 2) adoption of an unduly
informal approach to assessing causation from EDCs, 3) reliance on
disease trends to suggest associations with EDCs, and 4) disregard
for the role of exposure, dose and potency in endocrine disruption.
In the Lamb critique, the earlier WHO/IPCS (2002) report, to which
two of the authors (Foster, Van Der Kraak) contributed, is held up as
a positive example.
The overall claim of Lamb et al. (2014) that, “Overall, the 2012

report does not provide a balanced perspective, nor does it accurately reﬂect the state of the science on endocrine disruption.”
prompted us to analyze their critique and to respond in detail. We
approached this analysis openly. However, we discovered that the
conclusion of Lamb et al. (2014) was based on many distortions,
inaccuracies, false generalizations, non-scientiﬁc argumentation,
and erroneous claims. These are illustrated below.
2. Results
2.1. Does the odd missed reference constitute bias?
Throughout their paper, Lamb et al. claim that we have selectively cited literature without discussion of contradictory studies,
and have failed to consider alternative causes of effects, thus giving
the reader the impression that the weight of evidence for endocrine
disruption is stronger than is justiﬁed by the scientiﬁc data.
Importantly, to substantiate these general allegations, they resort to
a maneuver that can only be characterized as misdirection of the
reader. Speciﬁcally, they selected topic areas from the UNEP/WHO
report where the evidence for associations between chemical exposures and endocrine disruption is not very strong (and where
this was clearly stated in our report, for example adrenocortical
hyperplasia in seals, prostate cancer, poor semen quality), sought
out a few studies that were not cited, and make the sweeping
generalization that these omissions “call[s] into question the
integrity of decisions at all levels of the 2012 report”.
This kind of critique might make sense in the context of strongly
contested issues, but is misleading when directed at topics where
no strong claims are made regarding links between exposure and
effect, and where failure to include one or two additional studies
would not change the conclusion.
Accusations of bias and imbalance would have been justiﬁed, if
we had consistently ignored evidence pointing in a speciﬁc direction. However, a fair assessment of this question is only possible by
engaging scientiﬁcally with the substance, content and conclusions
of our report, something Lamb et al. avoid doing. Bias cannot be
inferred from the odd missed reference.
Instead of engaging with the scientiﬁc content of UNEP/WHO
(2013), Lamb et al. shift attention to methodological issues concerned with preconceived ideas of what might constitute a state of
the science review, and approaches to assessing causation and
weight of evidence. This tactic creates the false impression of bias,
imbalance and subjectivity. As we will discuss below (see Section
2.8), the tactics used by Lamb et al. have striking similarities with
those employed by the tobacco industry to undermine attempts of
introducing standardized packaging for cigarettes. These approaches were elucidated recently by Ulucanlar et al. (2014).
2.2. UNEP/WHO (2012) e not a state of the science assessment, nor
an update of the WHO/IPCS (2002) report?
During the 10 years that passed since publication of the WHO
2002 report, endocrine disruption research has deepened and
expanded our understanding of the endocrine system and the role
of chemicals in disrupting aspects of its functioning. A brief glance
at the range of new topics covered in UNEP/WHO (2013), and not
dealt with in the IPCS 2002 report, highlights the progress made.
While the 2002 report considered mainly male reproductive health,
the 2013 report documented the progress made in female reproductive health. In 2002, there was relatively little knowledge of
prostate, thyroid and ovarian cancer in endocrine disruption, but
since then, our insight has grown, as documented in the 2013
report. The last ten years have seen an improvement in our
knowledge of metabolic disorders and endocrine disruption, and
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this was taken up as a new topic in the 2013 report. While in 2002
the focus of wildlife effects was on ﬁsh and a small number of
mammals, this has expanded to invertebrates, amphibians, reptiles
and birds, all documented in the 2013 report. There have also been
signiﬁcant developments in cross-cutting issues, such as mixture
effects, which were not mentioned at all in the 2002 report. The
sheer explosion of knowledge can also be gleaned from comparisons of the length of the two reports and the number of papers
cited: more than 2200 references and 280 pages in the 2013 report,
versus 1400 references and 170 pages in WHO/IPCS (2002). The
main conclusions and advances in knowledge since 2002 are presented both in the “Executive summary” of the main report (UNEP/
WHO, 2013) and in chapter 13 of the Summary for Decision-Makers
(UNEP/WHO, 2013a), conﬁrming the extensive progress in EDC
related research over the last 10e15 years.
Not surprisingly, we were in a position to reach more reﬁned
and deﬁnitive conclusions than was possible in 2002. Yet, Lamb
et al. do not highlight the intense research activity that was
reviewed in the 2013 report, but claim that the 2013 report is
neither a state-of-the-science assessment, nor an update of the
earlier 2002 report, “but rather a reworking of that earlier report”
and support this claim with the assertion that the 2013 report
“reviews much of the same information cited in the 2002 report by
frequently citing literature from the year 2001 or earlier”.
While it is correct that we have cited literature from 2001 and
earlier, this was necessary to have complete coverage of the evidence and to place scientiﬁc developments into the appropriate
context. But to infer from this that the 2013 report is a mere
“reworking”, with the implication that we covered little new evidence, is a gross distortion of the facts. More than 75% of the citations (ca. 1650 citations) are publications that appeared from 2002
to 2013. Lamb et al. go even further when they write “The fact that
the 2012 report reaches more deﬁnitive conclusions based on the
same data emphasizes a reliance on subjective decision making
and less stringent criteria for evaluating potential causal relationships compared to the earlier 2002 report.” (emphasis added). This
creates the absurd impression that there has been little scientiﬁc
progress since 2002, and that, because we reached more deﬁnitive
conclusions than the 2002 report “based on the same data”, we
must be biased, subjective and imbalanced. These claims are
without any basis.
A recurring pattern of argumentation in Lamb's critique is to
construct arbitrary standards, highlight areas where the UNEP/
WHO (2013) report purportedly falls short of these arbitrary standards, and then move to the sweeping generalization that the
report must be fundamentally ﬂawed. This tactic is only viable by
avoiding any engagement with the scientiﬁc substance of the
report. It is by this approach that Lamb et al. (2014) come to the
surprising conclusion that UNEP/WHO (2013) is not a state-of-thescience report. Speciﬁcally, this conclusion is based on several
elements:
Lamb et al. note that “The report never deﬁnes what might be
meant by “state of the science” nor discusses what such an
assessment should cover and characterize.” They move on to ﬁll
this “gap” by deﬁning a state-of-the-science review as one that
“should have a deﬁned scope with a systematic approach to the
collection and review of data, and a clear methodology for the
integration and assessment of these data.”
Lamb et al. then criticize that a systematic approach to collecting
and reviewing data was not used in UNEP/WHO (2013). However,
this exposes a contradiction, which Lamb et al. do nothing to
resolve. On the one hand, they point out that the literature “is
extensive and beyond the scope of either the 2002 or 2012 report”
and concede that “neither report could be expected to undertake
complete reviews for even a small subset of chemicals”. On the

3

other hand, they assert that “a systematic methodology would have
ensured that a representative spectrum of the available literature
was captured in review”, but fail to deﬁne how identiﬁcation of
“representative” literature should be done in a systematic, objective
fashion. They ignore that any choice made will always be open to
the criticism of lacking a systematic approach to literature selection. Indeed, the same criticism can be leveled against the WHO/
IPCS (2002) report which used exactly the same approach as
UNEP/WHO (2013), but which Lamb et al. hold up as the example to
emulate. They fail to explain why they exempt the WHO/IPCS
(2002) document from that criticism.
Indeed, the ﬂexible standards of a state-of-the-science review
are illustrated in a document written in 2007 by two of the authors
critiquing the UNEP/WHO (2013) report, Hentz and Lamb. They
published a report for the Weinberg Group, entitled “2007 Update:
State of the Science and Policy for Endocrine Disruption”, dated
May 29, 2007, in which they summarize the scientiﬁc evidence and
policy actions relating to endocrine disruption on 14 pages, citing
only 21 references and without a systematic approach to collecting
and analyzing the literature. (This document was downloaded in
2011, but is no longer available on the www. On request, we are
happy to provide the document to anyone interested.)
Regarding a “clear method for the integration and assessment of
data”, Lamb et al. claim that “the 2002 report attempted to integrate information on exposure, toxicological testing (including
dose-dependence of effects), the ability of putative disruptors to
interfere with endocrine-mediated control, and patterns of
appearance of possibly endocrine-related effects in populations. In
contrast, the 2012 report discusses each of these elements independently and speciﬁcally declines to consider how these aspects
can be brought together to assess whether there are real and current endocrine disruption problems or how well an integrated view
of the scientiﬁc evidence can answer that question.”
This claim is false. The 2002 report did not integrate exposure
information and toxicological data. Such integration is a matter for
toxicological risk assessment, which was considered out of scope by
WHO and UNEP. Examination of both documents reveals that this
was applied equally to the UNEP/WHO (2013) and the WHO/IPCS
(2002) reports. Accordingly, the WHO/IPCS (2002) report discussed exposure data in a separate chapter, in the same way as
UNEP/WHO (2013).
2.3. Weight-of-evidence approaches and frameworks for
identifying, reviewing and evaluating data
Lamb et al. criticize the UNEP/WHO (2013) report for not
adopting a weight-of-evidence approach or a systematic framework for identifying, reviewing and evaluating data. At the heart of
their critique is the assertion that “the lack of a systematic approach
to assess causation for speciﬁc chemicals and associated health
outcomes resulted in conclusions that were predisposed to the
identiﬁcation of potential EDCs”. This statement is based on several
naïve assumptions, the ﬁrst of which is that a systematic approach
to assessing causation exists and is uncontroversial for endocrine
disrupting chemicals. Secondly, the statement assumes that the
application of a systematic approach completely protects against
bias by obviating the need for scientiﬁc judgments, when in fact
scientiﬁc judgments are part of the process of systematic reviews.
Finally, it is assumed that such “standardized approaches” will always yield the same “objective” assessment outcome. In this and
the following section we show that these ideas are illusory and are
based on gross simpliﬁcations of the debates about causality that
have taken place in the epidemiological and science philosophy
literature.
First, Lamb et al. ignore that a universally accepted weight-of-
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evidence method for endocrine disrupters does not yet exist, and
that it will be a considerable challenge to develop such an
approach. The methods that currently exist, e.g., for carcinogens
under the auspices of WHO IPCS (Sonich-Mullin et al., 2001; Boobis
et al., 2006) cannot readily be applied to endocrine disrupters,
mainly because an approach useful for EDCs will have to deal with
the issues of adversity and mode-of-action at the same time, which
is currently without precedent. A more detailed discussion of this
topic can be found in Kortenkamp et al. (2011).
It is important to stress that weight-of-evidence approaches
were also not used consistently throughout the WHO/IPCS (2002)
report, counter to the impression Lamb et al. create.
In fact, the authors of the 2002 report took a much more
nuanced stance than insinuated by Lamb et al. The 2002 report
acknowledged the difﬁculty of the task of creating objective and
unbiased assessments of whether endocrine disrupting chemicals
may have adverse effects. It was recognized that the challenges of
this task arise from the vast number of studies conducted, the
improbability that a single study can provide all the necessary information to link an exposure scenario to a particular health
outcome in wildlife or humans, and the diverse circumstances (e.g.,
varied experimental conditions, numerous endpoints) from which
data have been generated.
To deal with these difﬁculties, the authors of the 2002 report
proposed a framework for assessing the relationship between
exposure to endocrine disrupters and altered health outcomes. This
framework is a variation on the BradfordeHill criteria for assessing
causality in epidemiology. The approach taken in WHO/IPCS (2002)
was a tentative and cautious one in which the framework was tried
out in a series of case studies in a separate chapter at the end of that
report. It was introduced at the ﬁnal meeting of the authors of the
2002 report, with the intention of assessing the applicability of this
approach (cf. Tables 7.1 and 7.2, in WHO/IPCS (2002)). This is very
different from a consistent application of a framework for assessing
causality, and becomes evident from the articulation of several
caveats in WHO/IPCS (2002): “This structured, framework
approach acknowledges that 1) there are a number of scientiﬁc
uncertainties, 2) a degree of scientiﬁc judgment is involved, and 3)
assessments are likely to change as additional information becomes
available. (…) Also, it should be noted that these assessments are
qualitative determinations of the current overall state of the science. They are not quantitative risk assessments that relate speciﬁc
exposure situations to probabilities of adverse effects.”
Notable is the acknowledgment by the authorship of the WHO/
IPCS (2002) report of the need for expert scientiﬁc judgment, as
well as the delineation from quantitative risk assessment, which
Lamb et al. fail to state. Thus, scientiﬁc judgment comes to bear at
all stages of the process, including hypothesis formulation and
evaluation against BradfordeHill's criteria. Critical to this is the
framing of a hypothesis linking an outcome of concern to a putative
stressor, and this inﬂuences the outcome of the assessment most
strongly. If the hypothesis is formulated too narrowly, the entire
assessment may lose relevance, or even become erroneous. With
the beneﬁt of hindsight from 10 years' worth of research after 2002,
which led to the discovery of numerous chemicals as endocrine
disrupters, certain case study hypotheses in WHO/IPCS (2002) will
today be judged as artiﬁcially restricted, and with a rather limiting
focus on persistent organic pollutants such as PCBs, DDT or polychlorinated dibenzo-p-dioxins and dibenzofurans. For example, the
2002 report considered a case study of breast cancer, with the
following hypothesis: “Increased incidences of breast cancer are
caused by exposure to organochlorine chemicals (e.g., PCBs, DDT,
and metabolites) possessing estrogenic activity.” By application of
the BradfordeHill criteria of temporality, strength of association,
consistency and biological plausibility, the 2002 report concluded

that “the evidence is weak in support of the hypothesis that
exposure to PCBs, DDT, and other organochlorines contribute to
increased risk based on the lack of consistency of the results, weak
associations, and questions of biological plausibility”. This may well
be so, even today. However, today we know that a more meaningful
assessment of that question would focus not only on PCBs, DDT and
other organochlorines, but also take account of additional agents
revealed as xenoestrogens, as well as the issue of combination effects from simultaneous exposures to a large number of chemical
and non-chemical risk factors including genetics.
Thus, the use of criteria for assessing causality does not per se
safeguard against the temptation to buttress pet theories. As we
stated in the UNEP/WHO (2013) report, “it is important to use a
systematic and transparent approach to evaluating the scientiﬁc
evidence about the relationship between environmental exposure
and health effects”. Such approaches were developed over the last
20 years from clinical science and have helped to reduce bias while
integrating expert judgment, but their application to endocrine
disrupting chemicals is still in their infancy (NTP, 2015). We
explicitly recommended that “Efforts are needed to develop systematic and transparent approaches to identifying, evaluating and
synthesizing the scientiﬁc evidence for endocrine disrupters that
consider the science of endocrine action.”
It is misguided to think that the application of a framework in
itself protects against bias. Protection against bias is only possible
by applying rigorous scientiﬁc judgment for which a multitude of
approaches exists. In much the same way as in WHO/IPCS (2002),
the approach used in UNEP/WHO (2013) was that of a narrative
review, a method Lamb et al. construe as allowing for “a selective
presentation of information without a critical review of the data.”
Here, Lamb et al.'s shortfalls are clear: First they suggest that a
narrative review per se predisposes to selective presentation of
data, and secondly, they neglect to apply the same criticism to the
WHO/IPCS (2002) report.
2.4. The debate about the usefulness of BradfordeHill's criteria for
assessing causality
As disapprovingly noted by Lamb et al., the UNEP/WHO (2013)
report did not employ the framework for assessing causality that
was suggested in WHO/IPCS (2002). They write: “Most critically,
the lack of a formal framework or standardized approach to evaluate the data on speciﬁc chemicals and the potential causal association with adverse outcomes via an endocrine-mediated MOA is a
signiﬁcant shortcoming in the UNEP/WHO 2012 review (emphasis
added).” The stance here is that scientiﬁc judgments derived from
procedures not adhering to a process that complies with Lamb
et al.'s ideas of causality must be subjective: “In the absence of a
formal assessment of causation, subjective inference is relied on to
suggest causation.” Does this view hold any water?
We were not insensitive to the issues articulated by Lamb et al.
and present below a detailed discussion of the problems associated
with the BradfordeHill criteria as a tool for judging causality
(UNEP/WHO, 2013). These problems were recognized by BradfordeHill himself (Hill, 1965) and described by us in UNEP/WHO
(2013), but are consistently overlooked, not only by Lamb et al.
but also in the WHO/IPCS (2002) report.
BradfordeHill pointed out that the question of causality should
not be discussed in isolation, separated from the context in which
decisions have to be made whether to act on the available evidence,
e.g., by adopting preventative measures. Thus, evaluating evidence
is only one part of the decision making process, which must take
account of many other elements important in preventing exposures. He observed that “it almost inevitably leads us to introduce
differential standards before we convict. Thus on relatively slight
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evidence we might decide to restrict the use of a drug for earlymorning sickness in pregnant women. If we are wrong in
deducing causation from association no great harm will be done.
The good lady and the pharmaceutical industry will doubtless
survive. On fair evidence we might take action on what appears to
be an occupational hazard, e.g. we might change from a probably
carcinogenic oil to a non-carcinogenic oil in a limited environment
and without too much injustice if we are wrong. But we should
need very strong evidence before we made people burn a fuel in
their homes that they do not like or stop smoking the cigarettes and
eating the fats and sugar that they do like (emphasis added).”
Thus, even when the outcome of an assessment employing the
criteria suggests that the overall strength of association might be
weak, this does not automatically exonerate from a consideration of
protective measures. Lamb et al. are remiss in acknowledging that
the goal of the toxicological and epidemiological sciences is not to
provide assessments as an end in themselves, but to explore and
evaluate conditions that offer disease prevention and public health
initiatives. This cannot be realized by mechanical application of
criteria for causation in the style of checklists. It is well known
among epidemiologists that the implementation of preventative
measures that eliminate factors which only weakly contribute to
risks may reap disproportionately large beneﬁts in terms of public
health protection. An example would be excessive salt intake and
its (weak) association with hypertension. Regulating salt content in
foods could shift entire population distributions of blood pressure
downwards, thereby decreasing the prevalence of moderate and
severe hypertension (Szklo and Nieto, 2007). Lamb et al. ignore
these insights.
However, the problems with using BradfordeHill's criteria as a
tool for inferring causality go much deeper, and their uncritical use
trivializes the fundamental problems that exist with inferring
causality from empirical observations. Indeed, BradfordeHill himself (who never used the word “criteria” and instead chose the term
“viewpoints”) was fully aware of these problems when he stated
that “none of my nine viewpoints can bring indisputable evidence
for or against the cause and effect hypothesis and none can be
required as a sine qua non…what they can do is help us to make up
our minds on the answer to the fundamental question e is there
another way of explaining the set of facts before us”.
Lamb et al. ignore the debate of BradfordeHill's viewpoints and
the issue of assessing causality that has taken place in epidemiology
(summarized by, e.g., Rothman and Greenland, 2005), in which
epidemiologists have strongly refuted the existence of absolute
criteria for assessing causality. It is a widely held view among
experimental scientists that proof of causality is impossible in
epidemiology, with the implication that the situation in the
experimental sciences is better. However, David Hume's insight
that proof is impossible in all empirical sciences equally applies to
the experimental sciences, and Rothman and Greenland cite the
cold fusion debacle in support of this notion. Numerous additional
examples could be used to illustrate this.
Rothman and Greenland (2005) offered a speciﬁc critique of the
utility of BradfordeHill's criteria, and a discussion tailored to issues
relevant to endocrine disruption was presented by Zoeller et al.
(2014). Here, we summarize these points with reference to the
modiﬁed criteria used in the WHO/IPCS (2002) case studies:
The criterion of temporality explores whether the putative risk
factor precedes the occurrence of an effect in time. Insofar as any
inference of causation must stipulate that a cause has to act before
the effect can materialize, this criterion may appear clear-cut.
However, there are practical difﬁculties, as the temporal relationship between exposure to an EDC and a speciﬁc endocrinemediated adverse outcome may be quite complex. The classic
example is that of diethylstilbestrol (DES) exposure during fetal life
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and the production of reproductive tract cancer 20 years later, long
after DES exposure had ceased. This relationship was observed
because pregnant women were prescribed DES and because there
were speciﬁc records of exposure. This will not likely be the case for
most non-accidental exposures to EDCs. Thus, “temporality” may
be important, but it may be a concurrent relationship, i.e. exposures
that are measured at the same time as the health endpoints being
assessed (Zoeller et al., 2014). Furthermore, as Rothman and
Greenland (2005) pointed out, the observation of a reverse time
order between cause and effect (i.e., exposure and health outcome)
is not evidence against the hypothesis that the putative cause can
lead to the effect. Observations in which the cause followed the
appearance of an effect merely show that the putative cause cannot
have caused the effect in the instances that were considered.
However, the generalization that the hypothesized cause is therefore not linked to the effect is fallacious.
The criterion of strength of association expresses the sentiment
that strong associations are more likely to be causal than weak
associations, which are often explained by undetected bias. However, BradfordeHill himself did not rule out that a weak association
might suggest causality, and Rothman and Greenland (2005) cite
the weak association between smoking and cardiovascular disease
as an example. Despite the weakness of the association, no one
today would doubt that cardiovascular disease is causally linked
with smoking. The reason for the weakness of the relationship is
that cardiovascular disease is rather common and can be linked to
other factors, and the same applies to many endocrine disorders.
Conversely, there are examples of strong, but non-causal associations, and Rothman and Greenland (2005) point to the strong
relation between Down syndrome and birth rank which is
confounded by maternal age. These examples show that strong
associations between putative risk factors and diseases do not
necessarily indicate causality. The mere fact that an observed association is weak says nothing in terms of absence of causality.
The authors of WHO/IPCS (2002) have subsumed BradfordeHill's original viewpoint of speciﬁcity under that of strength of association. The criterion of speciﬁcity requires that a putative cause
leads to a single, recognizable effect. The example used by BradfordeHill (Hill, 1965) was that of nickel reﬁners of South Wales who
suffered from a high incidence of rare cancers of the lung or nose.
The speciﬁcity of this relationship could be used as evidence of
causation. However, BradfordeHill cautioned about making too
much of the speciﬁcity of the relationship and concluded that, “In
short, if speciﬁcity exists we may be able to draw conclusions
without hesitation; if it is not apparent, we are not thereby
necessarily left sitting irresolutely on the fence.” As it is unrealistic
to expect that a cause of a speciﬁc effect should lack other effects,
the criterion of speciﬁcity is of limited usefulness in assessing
causality. This point is particularly relevant to endocrine disruption
where putative causes must be evaluated carefully because hormone systems are involved in a great many processes which are
life-stage speciﬁc. For example, androgens play an important role in
the development of the male reproductive system in the fetus, but
in the adult, androgens are related to different processes in men
and women. Transient hypothyroidism in the adult can lead to
weight gain that is reversible but has long lasting effects on brain
function when occurring in fetal and neonatal life (Zoeller et al.,
2014).
Consistency expresses the notion that multiple studies should
demonstrate the same relationships between exposure and
outcome. However, as pointed out by Rothman and Greenland
(2005), lack of consistency does not rule out causality, because
some effects may be produced by their causes only under speciﬁc
circumstances or in speciﬁc regions of the world. This point is
particularly relevant for endocrine disruption considering the life-
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stage speciﬁcity and geographical variations of many effects (e.g.,
semen quality, see Section 2.5.1 below).
BradfordeHill insisted that “it will be helpful” if the causation
we suspect is biologically plausible, but he was careful not to demand this in absolute terms. He cautioned that the association
observed may be one new to science or medicine and therefore
should not be dismissed too light-heartedly as too odd. Likewise for
EDCs, biological plausibility will strengthen our conﬁdence in the
causal nature of relationships of interest. Moreover, our knowledge
of hormone actions will likely drive us to evaluate speciﬁc relationships. However, there is a great deal we have yet to learn
about the endocrine system, and the demand for complete
knowledge of the endocrine mechanism mediating a relationship
of interest is not achievable (Zoeller et al., 2014). There are
numerous examples where explanations, which to contemporary
observers appeared as lacking biological plausibility, turned out to
be the correct ones. Accordingly, Maclure (1985) maintained that
biological plausibility should be applied not to the outcome of a
study, as suggested in WHO/IPCS (2002), but to the hypotheses
under investigation, and pointed out “The more the data are contrary to prevailing thought, the more informative they are”.
Finally, evidence of recovery (originally termed “experiment” by
BradfordeHill) expresses the idea that occasionally, conﬁdence in a
conclusion of causality could be strengthened by changing elements of the environments and observing a predicted change. For
example, as a result of altered work conditions leading to a
reduction in dust exposures, the health of workers should improve.
BradfordeHill did not include animal or biochemical experiments
in this “viewpoint”. At a practical level, the main problem with this
“criterion” is the lack of relevant data, and indeed none of the case
studies examined in WHO/IPCS (2002) had relevant data to
examine this aspect. Furthermore, evidence of recovery is not a
criterion to assess outcomes and to infer causality, but rather is a
test of the underlying hypothesis, as was pointed out by Rothman
and Greenland (2005). In most cases, such tests are simply not
available, but even if they are, there is always room for alternative
explanations, often rendering such tests inconclusive in the sense
of establishing causality. An apt example of this is the discussion of
the recovery in mollusk populations in the wake of reductions of
exposure to TBT. Lamb et al. express doubts that this recovery is an
indication that TBT was the cause of the declines and marshal other
factors as possible explanations. In this case, the laboratory evidence linking cause and effect (in terms of TBT-induced imposex
and sterility as a highly sensitive and chemical-speciﬁc phenomenon) was irrefutable and it was this observation that led to rapid
control of TBT, not the evidence of population recovery that ensued
(Vos et al. 2000).
If there are no absolute criteria for assessing causality, is it still
possible to assess the validity of an experiment or a study?
Rothman and Greenland (2005) argue: “What is required is much
more than the application of a list of criteria. Instead, one must
apply thorough criticism, with the goal of obtaining a quantiﬁed
evaluation of the total error that afﬂicts the study. This type of
assessment is not one that can be done easily by someone who
lacks the skills and training of a scientist familiar with the subject
matter and the scientiﬁc methods that were employed. Neither can
it be applied readily by judges in court, nor by scientists who either
lack the requisite knowledge or who do not take the time to
penetrate the work.”
It was therefore appropriate and fully justiﬁed to abstain from
an uncritical use of BradfordeHill's criteria in the UNEP/WHO
(2013) report. In no way did this decision expose the report to
bias and imbalance. Nevertheless, we recognize the importance of
reaching a consensus about how to “weigh” results of epidemiological and toxicological studies and acknowledge the need for

developing such approaches tailored to the speciﬁc demands of
EDCs. This is discussed in more detail in Zoeller et al. (2014).
2.4.1. Response to speciﬁc examples chosen by Lamb et al. to
illustrate that lack of application of BradfordeHill's criteria leads to
subjective judgment
The way in which Lamb et al. used speciﬁc examples from the
UNEP/WHO (2013) report to substantiate their contention that our
decision not to employ BradfordeHill's viewpoints has led to subjective inference, can be used to illustrate the ﬂaw in the concept
that application of a framework for assessing causality per se will
resolve the issues surrounding scientiﬁc judgment and thus achieve “objectivity” by “standard” application of assessment criteria.
Lamb et al. propose that such a procedure, if only it were adopted
universally and liked by everybody, will always produce the same
conclusions. In this system, assessment outcomes that produce
deviating conclusions can only be the result of misapplication of
the assessment framework, and therefore have to be deemed
subjective. As we show below, this ignores that assessment outcomes depend strongly on the way in which questions for assessment are framed. However, hypothesis formulation cannot be
judged in categories of “objectivity”.
For example, when discussing prostate cancer and possible associations with endocrine disrupters, Lamb et al. take issue with the
statement in UNEP/WHO (2013) that there is sufﬁcient evidence for
associations between pesticide exposures and prostate cancer
among pesticide applicators. While not denying that such associations exist, Lamb et al. argue that before we can “convict” (to use
BradfordeHill's phrase) it is necessary to show that prostate cancer
is attributable to alterations in endocrine function in humans as a
result of exposure to putative endocrine disrupters. While the
sufferers of prostate cancer may not care much whether they
contracted the disease through an endocrine disrupting mechanism, a hypothetical producer of pesticides may well be interested
in resolving this rather speciﬁc question, in the interest of protecting themselves against recriminations that arise from the speciﬁcs of chemical regulation of endocrine disrupters. However,
while the question of associations of pesticide exposure with
prostate cancer can be resolved with currently available scientiﬁc
methods, “proof” that an individual cancer has arisen via alterations of endocrine function cannot be provided with methods
currently at our disposal, and probably never will be. Consequently,
a study question of whether pesticide exposures increase prostate
cancer risks and that this occurs through an endocrine mode of
action is very likely to yield inconclusive results. However, if the
study question is whether pesticide exposures increase the risk of
prostate cancer, the assessment will result in a better strength of
evidence. Thus, how the question is asked may matter more than
the approach used to answer it. This confusion about approach and
study question is promulgated by Lamb et al. But it is open to
debate whether the question, framed in the way Lamb et al.
advocate, has any meaning from the perspective of public health
protection, and whether that assessment can claim any
“objectivity”.
UNEP/WHO (2013) presented a more balanced discussion of the
issue. While highlighting the observed associations between
pesticide exposures and prostate cancer, the report pointed out that
the nature of the pesticides involved remains obscure, and that it
therefore remains unclear whether the cancers arose through an
endocrine-mediated mechanism. However, this lack of clarity does
not weaken the conclusion that the evidence linking pesticide
exposure among applicators to prostate cancer can be deemed
sufﬁcient.
The criticism formulated by Lamb et al. shows that the elusive
goal of objectivity cannot be achieved just by application of an
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assessment framework based on BradfordeHill's viewpoints in the
style of a checklist, because a great deal is determined by hypothesis formulation. However, as we have seen, hypothesis formulation itself cannot claim objectivity e hypotheses are framed in a
context of speciﬁc interests and are subject to scientiﬁc judgment.
The commercial interests supporting Lamb et al. will likely always
prefer articulation of hypotheses in the narrowest possible way and
such narrow hypotheses will, through application of “standard”
procedures, almost always return the standard verdict “inconclusive”, with the consequence of abstaining from recommendations
of emission-reducing measures. From the viewpoint of public
health protection, however, it is important to formulate more
meaningful hypotheses that take account of multiple exposures
and multi-causality.
2.5. Response to the speciﬁc examples of alleged imbalance and bias
highlighted by Lamb et al.
In the sections below we give speciﬁc responses to the examples
Lamb et al. (2014) selected from the UNEP/WHO (2013) report to
show “why and how the UNEP/WHO 2012 report is not an update of
the WHO-IPCS 2002 report…” and how bias and subjectivity
allegedly guided our analysis and our conclusions.
2.5.1. Semen quality
Lamb et al. highlight a “discrepancy” between the conclusions in
UNEP/WHO (2013) and WHO/IPCS (2002) about semen quality
which they ﬁnd “difﬁcult to explain” considering that “it does not
appear that the evidence for changes in sperm quality differ (sic)
from that reported in the WHO-IPCS (2002) report.” They conclude:
“When an objective, structured, and transparent weight-of-theevidence analysis reaches one conclusion and a subjective analysis concludes the opposite, logic dictates the driving force for such
a difference stems from the methodology and bias inherent in a
subjective analysis.”
However, the logic of this argumentation collapses when the
alleged discrepancy between the conclusions of the “objective,
structured and transparent” WHO/IPCS (2002) and our “subjective
analysis” in UNEP/WHO (2013) can be shown not to exist.
Two key issues surround the debate about semen quality: First,
have there been deteriorations of semen quality, and secondly, is
there any evidence of associations with endocrine disrupting
chemicals?
The WHO/IPCS (2002) report concluded that “Viewed as a
whole, several of the published reports support the hypothesis that
there are time-related decreases in semen quality at least within
some regions, as reﬂected in sperm concentration and, where
measured, sperm motility and morphology, but do not support the
hypothesis that the decline is worldwide.” By analyzing the available studies using BradfordeHill's viewpoint of consistency, the
2002 report listed ten studies showing a decline, six studies with
evidence for improvement and eight studies where no change was
found. It was clear already in 2002, that changes in semen quality
strongly depended on location, among other factors, and that a
world-wide decline was not supported by the data.
Lamb et al. disregard that, like the WHO/IPCS (2002) report,
UNEP/WHO (2013) highlighted the geographical variations in
semen quality that were apparent also in the new studies conducted after 2002. The 2013 report made no claims about worldwide declining trends. However, Lamb et al. base their allegation
of bias and selective citation on the fact that we did not cite four
studies of semen quality which did not report semen quality deteriorations. They mislead the reader by obscuring that citation of
these studies would not have altered our conclusion that a worldwide decline does not exist, but that there are regions with
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alarming declines. Citation of these studies would therefore not
have added anything to our report.
Importantly therefore, the undisputed fact of geographical variations cannot distract from observations of alarming declines in
semen quality in some regions, and this was emphasized in UNEP/
WHO (2013). Lamb et al. confuse the issue by criticizing the 2013
report for focusing on the decreased semen quality, thereby
“ignoring the variability in sperm quality reported around the
world”. This misses the point entirely and is an example of misuse
of BradfordeHill's viewpoint of consistency. As emphasized earlier,
a lack of consistency does not rule out causality, and cannot be used
to argue away that some populations have experienced declines in
semen quality.
Lamb et al. further make the false allegation that UNEP/WHO
(2013) did not discuss limitations and biases of semen quality
studies, when in fact our report pointed out that “The reason for the
controversy may partly be explained by…differences in methods
for semen analysis and variation in results within individuals…”.
Regarding the issue of associations of declines in semen quality
with exposures to endocrine disrupting chemicals, Lamb et al.
claim that UNEP/WHO (2013) used observations of suboptimal or
poor semen quality in some parts of the world to “suggest that
these perceived trends are the consequence of exposure to endocrine disruptors with no strong evidence to support this claim”
(emphasis added). To pause on the effrontery of re-interpreting
data of observed semen quality declines as “perceived” trends
would indeed miss the point: UNEP/WHO (2013) clearly states “A
role for EDCs has been hypothesized, but to date there are no clear
data except for some rare cases of environmental or occupational
accidents.” This conclusion is not different from WHO/IPCS (2002),
but this fact is omitted by Lamb et al.
The 2013 report highlights the difﬁculties in unraveling the
possible contribution of endocrine disrupting chemicals that stem
from prenatal exposures. The few studies of possible associations
with chemicals have all focused on exposures experienced in
adulthood, and may therefore have missed periods of heightened
sensitivity in fetal or neonatal life, another point entirely disregarded by Lamb et al.
Regarding semen quality, the main conclusion of the UNEP/
WHO (2013) report is that semen quality among 20e40% of
young men in several European countries is in the sub fertile range.
This conclusion is based on new studies conducted after 2002, but
does not disagree with the trends already discernible in WHO/IPCS
(2002). The 2013 report also concludes that “there is, however, very
little direct evidence for a role of endocrine disrupting chemicals in
causing low semen quality in men following developmental exposures”, quite similar to the stance taken in WHO/IPCS (2002).
Thus, what Lamb et al. declare as a “discrepancy” between the
conclusions of the two reports is nothing but exaggeration and
misdirection. Their claim that UNEP/WHO (2013) has “concluded
the opposite” and that “the driving force for such a difference stems
from the methodology and bias inherent in a subjective analysis [of
UNEP/WHO, 2013]” is baseless and the result of an extraordinary
distortion of the facts by misquoting the evidence.
2.5.2. Adrenal disorders
The way in which UNEP/WHO (2013) dealt with the issue of
population declines and adrenocortical hyperplasia in Baltic seals
and its possible association with persistent organic pollutants is
cited by Lamb et al. as a speciﬁc example of “selective citation of
literature without discussion of contradictory studies and the failure to consider alternative causes of reported effects” which gives
the reader “the impression that the weight of evidence is stronger
than is justiﬁed by the available scientiﬁc data”. They go on to claim
that this “calls into question the integrity of decisions at all levels of
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the 2012 report”.
In their attempt to substantiate these serious allegations, Lamb
et al. misrepresent both the WHO/IPCS (2002) and the UNEP/WHO
(2013) report.
They write that “it was stated in the 2002 report that although
adrenal effects in wildlife were associated with dichloro-diphenyldichloroethane (DDD), DDT, and PCBs, the involvement of these
compounds in the cause of these disorders was uncertain.”
However, in contrast to the portrayal by Lamb et al., the 2002
report actually stated that “Although overhunting and habitat
destruction may have been contributing factors, it is generally
accepted that persistent pollutants, which adversely affected the
reproductive performance of the females, resulted in the decline
in seal numbers.” The issue was also chosen as one of the case
studies for evaluating causality, and the WHO/IPCS (2002) came to
the conclusion that the overall evidence that persistent organic
pollu-tants including PCBs contribute to reproductive toxicity in
Baltic seal through an endocrine mechanism is moderate, but not
uncertain as claimed by Lamb et al. In the overall assessment the
2002 report states: “Relative to the outcome of concern [reproductive failure in Baltic seals] there is considerable evidence that
the reproductive success of Baltic seal populations has been
impacted and that these exposures have altered adrenal gland
function in members of the exposed population. However,
because the link between altered adrenal function and reproductive impairment has not been clearly established, the overall
evidence of an EDC-related mode of action is moderate (emphasis
added).”
Since 2002, new evidence concerning adrenocortical hyperplasia in Baltic seals and a suite of alterations characteristic for Cushing
disease in humans has come to light, disregarded by Lamb et al., but
discussed in UNEP/WHO (2013). Nevertheless, the position adopted
in UNEP/WHO (2013) is much more nuanced than Lamb et al.
suggest. The 2013 report emphasizes that “the exact mechanisms
behind the Cushing-like condition remain unclear. Likewise, the
individual compounds producing these adrenal lesions remain
unknown. Although it cannot be ruled out that a component of
stress was playing a role, it seems likely that persistent exposure to
organohalogens were involved.” Thus, Lamb et al.'s claim of selective citation of literature without consideration of alternative explanations in the UNEP/WHO report is without substance.
2.5.3. Endometriosis
The way in which UNEP/WHO (2013) dealt with the topic of
endometriosis is also held up by Lamb et al. as an example of selective citation of evidence. More speciﬁcally, Lamb et al. stress that
“the UNEP/WHO 2012 discussion on endometriosis is not an update
of the WHO-IPCS 2002 report as it mainly consists of a re-review of
the information evaluated in 2002”. They go on to say “It is not clear
what, if anything, has changed regarding the state of the science in
terms of cause and effect for endocrine disruption and endometriosis since the WHO-IPCS report”. These claims are false and a
marked distortion of the content of the 2013 report.
UNEP/WHO (2013) deals with the topic by ﬁrst giving an
explanation of the natural history of endometriosis, with new information about the increasing disease incidence, and an update
about risk factors, based on no fewer than 14 publications that
appeared after 2002 and which, therefore, were not included in
WHO/IPCS (2002).
UNEP/WHO (2013) then proceeds to a discussion of hormonal
mechanisms implicated in endometriosis, with the relatively new
hypothesis that the origin of this disorder might be in fetal life. The
involvement of the immune system and the necessity of estrogens
for disease progression are also considered. Nine references with a
publication date after 2002 are cited to substantiate this discussion.

The 2013 report then turns to describing animal models of
endometriosis. In relation to this discussion Lamb et al. claim that we
failed to note that many of the studies linking TCDD to endometriosis
employed high doses of TCDD. This criticism is also misleading, since
in fact we wrote that “this includes a study of twenty rhesus monkeys
dosed and followed for 15 years, which reported an increase in
incidence and severity with higher dioxin exposures”.
The section on animal models details four publications that
appeared after 2002. These studies provide evidence for the
involvement of epigenetic changes in endometriosis and in support
of the idea that such changes can be induced by in utero exposure
to chemicals.
Finally, the UNEP/WHO (2013) considers epidemiological evidence for the involvement of endocrine disrupters in endometriosis
and highlights that most available studies focused on adults, with
the implication that periods of heightened sensitivity (e.g., exposures in fetal life) might have been missed. This section of the
report mentioned seven studies that did not report any associations
between endometriosis and environmental exposures, of which
ﬁve appeared after 2002. There were, however, associations with
PCBs and six studies were cited in support of this idea, of which four
appeared after 2002. The 2013 report also mentioned the associations between endometriosis and phthalate esters (nine studies, of
which seven appeared after 2002) and one study reporting a link
with cadmium. Only one study was reported that dealt with fetal or
early life exposures to DES. We also highlighted that there is a
strong genetic component in endometriosis and that certain genotypes might be particularly susceptible to the disease.
Considering these details, it is difﬁcult to recapitulate how Lamb
et al. (2014) could arrive at the conclusion that “it is not clear what,
if anything, has changed regarding the state of the science in terms
of cause and effect for endocrine disruption and endometriosis
since the WHO-IPCS report” and that “this illustrates that the
UNEP/WHO 2012 report is not an update of the WHO-IPCS 2002
report”.
2.6. What do temporal trends in diseases show?
The UNEP/WHO (2013) report recorded incidence trends of
many endocrine-relevant disorders and emphasized that worldwide, there has been a failure to adequately address the underlying environmental causes of these trends. We highlighted that the
increase in disease incidence and prevalence has occurred too fast
for genetic causes to provide plausible explanations, and concluded
that environmental factors in a wider sense must be at play. These
factors include diet, exercise, lifestyle factors and chemical exposures. Lamb et al. claim our report did not acknowledge that “much
of the time, the environmental causes of the diseases being discussed are not chemicals exposures.” This claim is false. We have
acknowledged non-chemical risk factors on numerous occasions,
but due to the topic of our report, had to focus on the issue of
chemical exposures.
In a familiar pattern, Lamb et al. then allege that “through selective citation in the UNEP/WHO 2012 report, an impression is
created that certain diseases have an increasing incidence or
prevalence.” In support of their claim, they point out that several
papers were cited in our report to indicate rising prevalence of
hypospadias, but that we did not cite Fisch et al. (2010) who stated
that “a review of the epidemiological data on this issue amassed to
date clearly demonstrates that the bulk of evidence refutes claims
for an increase in hypospadias rates.” That paper was indeed not
cited, and for good reason: Fisch et al. is an analysis that explores
the absurd hypothesis that hypospadia incidences have risen in
every country. They succeeded in demolishing that hypothesis, only
to conclude that, consequently, rising incidence of hypospadias is
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not occurring anywhere. We ensured that papers of such low
standards were excluded from consideration.
In their discussion of wildlife population declines Lamb et al.
(2014) attempt to cast doubt on the effects of TBT on gastropods
and of DDT/DDE on bird egg shells. Concerning the effects of TBT on
gastropods, Lamb et al. (2014) dismiss the statement of
€rundsdottir et al. (2005) that the impacts on gastropods around
Jo
larger harbors are presumably associated with the continued use of
TBT, on the grounds that no measurements of TBT concentrations
were made. However, in a more recent paper, the same research
group (Gudmundsdottir et al., 2011) ﬁnds a strong correlation between organic tin concentrations and imposex in the dogwhelk
Nucella lapillus. Morton (2009) is cited by Lamb et al. (2014) in
support of the idea that “due to lack of conﬁrmatory chemical data,
the changes in population size, structure, and reproduction herein
reported upon for N. lapillus cannot be correlated positively with
changes in the ambient TBT levels”. Here, Lamb et al. (2014) quote
out of context and omit the continuation of Morton's sentence “…
but they can and are correlated with freedom from imposex. This is
the ﬁrst time such a dramatic recovery from imposex, following the
banning of TBT, has been documented”.
Lamb et al. (2014) emphasize the lack of sensitivity of a number
of gastropod species to TBT-induced imposex; however, this is
misleading. The fact that one species may be less sensitive is
irrelevant to an assessment of the effects in a more sensitive species. Moreover, this emphasis on species that appear insensitive to
TBT distracts from the fact well known to ecotoxicologists that
imposex has been reported in over 170 species of neogastropod
mollusks to date; hardly a small number.
Lamb et al. (2014) assert that “the WHO-UNEP 2013 report does
not note the lack of agreement among researchers on the mechanism for induction of effects” in mollusks. This is false; page 46 in
the WHO-UNEP (2013) report says “Although the effects of TBT on
the reproductive system of female gastropods are well-established,
the underlying mechanisms are not yet understood”. Following this
statement, four suggested mechanisms e which do not mutually
exclude each other e are described.
Discussing DDT and its effects on bird populations, Lamb et al.
(2014) reference Henny et al. (2010) to state that “a number of
confounding factors are likely to have affected the recovery of
Osprey populations”. Several species of predatory and ﬁsh-eating
birds were severely affected by the exposure to DDT/DDE and it is
true that the recovery of some of these bird species in some
geographical regions was aided by various kinds of management
(i.e., supplying nest sites). However, this does not change the fact
that exposure to DDT/DDE caused the population declines in the
ﬁrst place and that the decreasing environmental concentrations of
DDT after the ban was a requirement for the re-establishment of the
populations. As with the case of TBT, it was experimental data
gleaned from a number of laboratory studies that clearly conﬁrmed
the reality of the epidemiological link between DDT/DDE exposure
and the effects in birds and not only the recovery of the bird
populations.
Lamb et al. (2014) also use the example of ospreys and
decreasing DDE concentrations in their general attempt to discredit
the scientiﬁc credibility of the UNEP/WHO 2013 report. Lamb et al.
(2014) call it a mischaracterized citation that we have drawn a best
ﬁt line through the values on DDE concentrations taken from
Henny et al. (2010) because such a line was not drawn by the
original authors. However, a simple regression on Henny et al.'s
(2010) data clearly shows a decreasing trend (p ¼ 0.003;
r2 ¼ 0.91). In the scientiﬁc literature, there are numerous examples
of similar decreases of DDT/DDE concentrations in various organisms after the ban of DDT (some of them presented in ﬁgure 3.18
and 3.40 in the UNEP/WHO, 2013 report).
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Lamb et al. (2014) repeatedly praise the WHO/ICPS (2002)
report for its approach and quality. For the overall assessment of
the effects of TBT and DDT/DDE, it is noteworthy that in the 2002
report (WHO/IPCS, 2002) (to which two of the co-authors of Lamb
et al. (2014), Foster and Van Der Kraak, contributed) the overall
strength of the evidence was assessed as ‘strong’ for the association
between exposure to TBT and the induction of imposex in marine
gastropods (both for the hypothesis and for the EDC mechanism).
For the association between eggshell thinning in colonial water
birds and DDE, the hypothesis and evidence for EDC mechanism
were assessed as ‘strong’ and ‘moderate’, respectively. It is unclear
what information led Foster and Van Der Kraak to cast doubt on the
UNEP/WHO 2013 assessments in the Lamb et al. critique, since they
do not differ from the assessments made in WHO/IPCS (2002).
2.7. The debate about doseeresponse relationships and potency
Lamb et al. discuss features of doseeresponse relationships in
the context of the characteristics of the endocrine system. They
criticize our perceived failure to discuss that “the endocrine system
is speciﬁcally designed to respond to environmental ﬂuctuations
and such homeostatic responses generally are considered normal,
adaptive, and necessary as long as they are transient and within the
normal homeostatic range”. As already discussed by Zoeller et al.
(2014), this criticism misses the point of endocrine disruption
entirely. By focusing on the role of the endocrine system in maintaining homeostasis, Lamb et al. ignore that the endocrine system
also has the role of programming development and fail to discuss
that disruption of the programming functions of the endocrine
system during speciﬁc windows of susceptibility can have irreversible consequences. They misconstrue our report when they say
that “the report suggests that at vulnerable developmental stages
potency may not be very relevant”. Potency is of course relevant,
but it cannot be the sole and decisive criterion when it comes to
regulating endocrine disrupters. Timing of exposure, irreversibility
of effect and other criteria also have to be considered (Kortenkamp
et al., 2011).
Lamb et al. also present a summary of the debates surrounding
the topic of non-monotonic doseeresponse relationships, but
criticize the review by Vandenberg et al. (2012) rather than the
UNEP/WHO (2013) report, confusing the positions articulated in
Vandenberg with those in our report.
2.8. Similarities with misrepresentations of scientiﬁc evidence used
by the tobacco industry to block contemporary tobacco regulation
The techniques used by Lamb et al. to discredit UNEP/WHO
(2013) have striking similarities to those currently employed by
the tobacco industry in the ongoing debate about tobacco regulation through standardized packaging intended to remove all brand
imagery and text. An analysis conducted by Ulucanlar et al. (2014)
of tobacco industry interventions shows how these are based on a
number of techniques designed to misrepresent the scientiﬁc evidence. Many of these techniques were also used by Lamb et al.
(2014).
At the most basic level there is misleading quoting of evidence
through inaccurate reporting of study objectives, methods and
ﬁndings. This involves what is referred to as the “tweezers” method
of partially and selectively quoting the original source, thereby
omitting qualifying information (Ulucanlar et al., 2014). Lamb et al.,
knowingly or not, have used this technique most frequently in
relation to the WHO/IPCS 2002 report, by distorting the methods
used in that report and by omitting qualifying statements particularly in relation to the use of BradfordeHill's viewpoints. Other
examples of the “tweezers” method can be found in the way Lamb
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et al. frame the debate about TBT and DDE and their effects on
wildlife.
A second tactic identiﬁed by Ulucanlar et al. (2014) in tobacco
industry submissions and also widely observed in the Lamb et al.
critique can be called “mimicked scientiﬁc critique”. It involves the
detailed inspection of scientiﬁc reports for methodological rigor
with the aim of rejecting an entire body of evidence as ﬂawed or
biased. In reaching that conclusion, scientiﬁc methods of critique
appear to be used, but only close examination of the approach reveals that these critiques are embedded in an essentially unscientiﬁc paradigm. As identiﬁed by Ulucanlar, these interventions are
“mimicked” versions of scientiﬁc critique because they seek
methodological perfection by judging studies against unrealistic
and perfectionist criteria, and insist on methodological uniformity,
among others.
In the preceding sections we have identiﬁed several examples
where Lamb et al. judged scientiﬁc studies against unrealistic
criteria, such as in the discussion of TBT and DDE and wildlife effects or in the framing of study questions in epidemiology in terms
of very narrow hypotheses (“prostate cancer as a result of endocrine mechanisms”).
As pointed out by Ulucanlar et al. (2014), this tactic works at a
deeper level than the “tweezers” method, because its identiﬁcation
and critique requires a good epistemological understanding of
science, specialized expertise, knowledge of research traditions and
methodologies and deep skills in interpretative analysis, all of
which are unlikely to be found among non-specialists and decision
makers in the civil service or similar bureaucracies.
In dismissing UNEP/WHO (2013) as ﬂawed and biased on the
grounds that a narrative synthesis of the evidence was used, rather
than a more quantitative meta-analysis, Lamb et al. insisted on
methodological uniformity whereby extremely narrowly deﬁned
standards are used to dismiss any review that does not ﬁt their
preferred approach. Narrative synthesis, as used in UNEP/WHO
(2013) and, counter to the claims of Lamb et al., also in WHO/IPCS
(2002), is an established method with authoritative guidelines
available for its conduct (Centre for Review and Dissemination,
2009). In insisting on methodological uniformity, Lamb et al.
display a fundamental failure to understand the requirement for
methodological pluralism in science.
2.9. State of the Science of Endocrine Disrupting Chemicals 2012 e
summary for decision-makers
Lamb et al. state that “The relationship between the 2012 main
report and the Summary for Decision-Makers is confusing at best.
Based on the title of this document, one might presume that this
document is a summary of e or at least based on the analysis of e
the main report. But a closer look reveals that the Summary is
actually characterized as ‘‘another product’’ of the process.” The
Summary for Decision-Makers is indeed not an executive summary
of the main report. An executive summary is contained in the main
report. Instead the “Summary for Decision-Makers” was written to
help non-scientiﬁc experts and especially decision makers, to understand the science reported in UNEP/WHO (2013). This practice is
commonly applied by intergovernmental organizations, a detail
overlooked by Lamb et al. (2014). Lamb et al. (2014) also fail to see
that the scientiﬁc substance of the Summary for Decision-Makers
does not differ from that of the UNEP/WHO (2013) report, despite
the stylistic differences they misleadingly emphasize.
3. Conclusions
We conclude that the criticism of the UNEP/WHO (2013) report
presented by Lamb et al. is without basis. It creates the false

impression of scientiﬁc controversy and does not engage with the
scientiﬁc substance of our report. As we have shown, Lamb et al.’s
attempt of deconstructing the UNEP/WHO (2013) report is not
particularly erudite scientiﬁcally. It appears that the critique is not
intended to be persuasive to the scientiﬁc community, but is
designed to speak to bureaucrats, politicians and other decision
makers not intimately familiar with the topic of endocrine
disruption and therefore susceptible to false generalizations of bias
and subjectivity. It is important to recognize that while we drafted
this response, evidence has come to light of sustained and
concerted lobbying efforts by American and European chemical
industries aimed at delaying European Commission efforts to
implement regulations for endocrine disrupters (Horel, 2015),
especially in the context of the ongoing negotiations of the Transatlantic Trade and Investment Partnership (TTIP) between the USA
and the EU. Importantly, many of these same lobbying organizations have funded the critique by Lamb et al. (2014). The alignment
of the conclusions of Lamb et al. with the goal of the lobbying efforts of their funders certainly creates the appearance of a conﬂict
of interest. Moreover, Lamb et al.'s lack of focus on scientiﬁc issues
and the similarity in their type of criticisms with those developed
by the Tobacco Industry make it difﬁcult to conclude anything but
that the funders recruited writers known to have industry-friendly
themes in their historical writing to “critique” the 2013 UNEP/WHO
report.
Finally, the concept of “controversy” in science must be viewed
appropriately, as articulated well by Blaise Pascal in the 1600s
(Auden and Kronenberger, 1966): “Contradiction is not an indication of false, nor is lack of contradiction a sign of truth.”
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